文献速递肾移植

早期监测活检中巨噬细胞密度预测未来移植肾功能

Macrophage density in early surveillance biopsies predicts future renal transplant function.
PubMed 文献 · Kidney Int · 2017-03-27

本研究通过数字图像分析早期监测活检中白细胞密度,探讨趋化因子受体基因型的作用及白细胞亚群对移植肾功能的预测价值。发现肾皮质CD68密度高于中位数与更低的患者和移植物联合生存率显著相关(HR 3.5,95%CI 1.1-11.0),且CD68密度是预测四年后eGFR低于30ml/min的显著指标(OR 7.4,95%CI 1.8-31.0),并在独立队列中验证。

要点

  • 早期监测活检中CD68+巨噬细胞密度高于中位数预测更差的移植肾生存。
  • CD68密度是四年后eGFR<30ml/min的独立预测因子。
  • CCR2 V64I基因型与较低的CD3和CD209密度相关。

核心结论

  • 早期监测活检中CD68+巨噬细胞密度的数字高分辨率评估显著改善移植肾活检的预后价值。

研究设计与样本

  • 在六周监测活检中,对全切片扫描评估T细胞(CD3)、B细胞(CD20)、巨噬细胞(CD68)和树突状细胞(CD209)密度,并分析趋化因子受体基因型及白细胞亚群对移植肾功能的预测价值,另在第二独立队列中验证。

主要发现

  • 肾皮质CD3、CD20和CD68在组织学排斥反应中显著更高。
  • CCR2 V64I基因型与较低的CD3和CD209密度相关。
  • CD68密度高于中位数与更低的患者和移植物联合生存率显著相关,风险比为3.5(95%CI 1.1-11.0)。
  • CD20和CD68密度均与移植后四年的估算肾小球滤过率(eGFR)呈负相关,且CD68与eGFR下降相关。
  • 在包括完整Banff分类的组织学指标中,仅CD68密度是四年后eGFR低于30ml/min的显著预测因子(比值比7.4,95%CI 1.8-31.0),并在多变量线性回归分析中构成最佳eGFR预测集的一部分。

临床怎么用

  • 可考虑在早期监测活检中采用数字图像分析量化CD68+巨噬细胞密度,以辅助预测移植肾远期功能和生存。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Inflammation impairs renal allograft survival but is difficult to quantify by eye at low densities. Here we measured leukocyte abundance in early surveillance biopsies by digital image analysis to test for a role of chemokine receptor genotypes and analyze the predictive value of leukocyte subsets to allograft function. In six-week surveillance biopsies, T-cell (CD3), B-cell (CD20), macrophage (CD68), and dendritic cell (CD209) densities were assessed in whole slide scans. Renal cortical CD3, CD20, and CD68 were significantly higher in histologic rejection. The CCR2 V64I genotype was associated with lower CD3 and CD209 densities. Above-median CD68 density was significantly associated with lower combined patient and graft survival with a hazard ratio of 3.5 (95% confidence interval 1.1-11.0). Both CD20 and CD68 densities inversely correlated with estimated glomerular filtration rate (eGFR) four years after transplantation. Additionally, CD68 correlated with eGFR loss. Among histological measurements including a complete Banff classification, only CD68 density was a significant predictor of an eGFR under 30ml/min after four years (odds ratio 7.4, 1.8-31.0) and part of the best eGFR prediction set in a multivariable linear regression analysis of multiple clinical and pathologic parameters. In a second independent cohort, the original CD68 median maintained its discriminative power for survival and eGFR. Thus, digital high-resolution assessment of CD68+ leukocyte infiltration significantly improves prognostic value of early renal transplant biopsies.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Bräsen JH, Khalifa A, Schmitz J, et al. Macrophage density in early surveillance biopsies predicts future renal transplant function. Kidney Int. 2017. PMID: 28359537. doi:10.1016/j.kint.2017.01.029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。